Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

With METROPOLIS's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 1.17500
forwardPE 42.79193
debtToEquity 15.29500
earningsGrowth -0.19700
revenueGrowth 0.04300
grossMargins 0.77241
operatingMargins 0.10135
trailingEps 28.20000
forwardEps 0.00000

The current ratio for METROPOLIS is 1.175, indicating that the company can service its short-term debt using available cash and assets. This suggests METROPOLIS has strong liquidity, with more than enough resources to meet its immediate financial commitments.
METROPOLIS's low Debt-to-Equity ratio indicates that the company isn't over-leveraged, suggesting it maintains a healthy balance between debt and equity. This lowers financial risk and points to a stable financial foundation, reassuring investors of the company's financial health.
METROPOLIS's low growth in both earnings and revenue indicates a likely decrease in profits. This suggests the company may be facing financial challenges, and investors should be cautious about its future performance.
METROPOLIS's negative gross and operating margins indicate that the company is not generating profit from either production or day-to-day operations. This could suggest cost overruns or declining revenue, impacting its financial stability.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

METROPOLIS's price has consistently remained near the lower edge of projections, suggesting that it is not fully meeting market expectations. This could indicate a need for improved performance or strategies to boost investor confidence.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


There were 2 METROPOLIS sales transactions, at market price of 2095.9249267578125.No sell transactions occurred during the period under consideration.Metropolis Healthcare Limited's current price levels are experiencing more buying activity than selling, which may point to a favorable outlook. This trend suggests investor confidence in the stock's future, potentially indicating expectations of continued growth.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


METROPOLIS has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view METROPOLIS as a stable option to park their money and potentially benefit from the company's continued growth and profitability.